Godavari Drugs

Godavari_Drugs03 May 2024

Pharmaceuticals

₹

-0.50 (-0.50%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Godavari Drugs

Godavari Drugs

Pharmaceuticals

Godavari_Drugs03 May 2024

₹

-0.50 (-0.50%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
06-Feb-2024	BC	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listi	13-Feb-2024
13-Feb-2024	BC	Outcome of the Board Meeting of Godavari Drugs Limited (the Company) held on Tuesday 13th February, 2024	13-Feb-2024
07-Nov-2023	BC	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve un-audited financial results for the quarte	14-Nov-2023
21-Jul-2023	BC	AGM:12.08.2023 Submission of voting results pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Report of Scrutinizer pursuant to Secti	12-Aug-2023
03-Aug-2023	BC	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve GODAVARI DRUGS LTD. has informed BSE that t	11-Aug-2023

No Rights has been declared by Godavari_Drugs

Book Closure

Record Date	Split Date	Purpose
13-Feb-2024	01 Jan'1900	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listi
13-Feb-2024	-	Outcome of the Board Meeting of Godavari Drugs Limited (the Company) held on Tuesday 13th February, 2024
14-Nov-2023	-	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve un-audited financial results for the quarte
12-Aug-2023	-	AGM:12.08.2023 Submission of voting results pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Report of Scrutinizer pursuant to Secti
11-Aug-2023	-	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve GODAVARI DRUGS LTD. has informed BSE that t

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Godavari Drugs Ltd ₹100.00(-0.50/-0.50%)	100.00	-0.50	75.30	27.96	18.55	2.15
Astrazeneca Pharma India Ltd ₹5,424.45(+90.60/1.70%)	5,424.45	+90.60	13,561.13	71.45	85.02	20.71
Bliss GVS Pharma Ltd ₹119.10(-10.10/-7.82%)	119.10	-10.10	1,246.87	56.07	18.27	1.28
Cipla Ltd ₹1,424.75(+5.20/0.37%)	1,424.75	+5.20	115,033.60	54.70	34.98	4.44
Amrutanjan Health Care Ltd ₹775.50(-11.10/-1.41%)	775.50	-11.10	2,242.02	27.78	50.95	8.56
Abbott India Ltd ₹26,144.45(-459.90/-1.73%)	26,144.45	-459.90	55,556.96	15.92	48.50	17.87

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	43.11	39.54	35.42	37.37	39.16	40.55
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	43.11	39.54	35.42	37.37	39.16	40.55
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.05	0.00	0.45	0.39	0.30	0.13
Total Income	43.16	39.55	35.87	37.76	39.46	40.68
Total Expenditure	39.65	36.48	33.17	34.69	36.89	37.98
PBIDT	3.51	3.07	2.70	3.07	2.57	2.70
Interest	1.27	1.30	1.11	1.03	1.10	1.06
PBDT	2.24	1.77	1.59	2.04	1.47	1.64
Depreciation	0.50	0.49	0.47	0.50	0.51	0.47
Tax	0.52	0.42	0.31	0.21	0.29	0.31
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	1.22	0.86	0.81	1.33	0.67	0.86
Extra-ordinary Items	-0.04	0.00	0.00	0.20	0.00	0.00
Adjusted Profit After Extra-ordinary item	1.26	0.86	0.81	1.13	0.67	0.86

EPS (Unit Curr.)	1.62	1.14	1.08	1.77	0.89	1.15
EPS (Adj) (Unit Curr.)	1.62	1.14	1.08	1.77	0.89	1.15
Calculated EPS (Unit Curr.)	1.62	1.14	1.08	1.77	0.89	1.15
Calculated EPS (Adj) (Unit Curr.)	1.62	1.14	1.08	1.77	0.89	1.15
Calculated EPS (Ann.) (Unit Curr.)	6.49	4.55	4.30	7.07	3.55	4.59
Calculated EPS (Adj) (Ann.) (Unit Curr.)	6.49	4.55	4.30	7.07	3.55	4.59
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	7.53	7.53	7.53	7.53	7.53	7.53
Reserve & Surplus	0.00	0.00	0.00	25.89	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	8.14	7.76	7.62	8.22	6.56	6.66
PBDTM(%)	5.20	4.48	4.49	5.46	3.75	4.04
PATM(%)	2.83	2.18	2.29	3.56	1.71	2.12

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	7.53	7.53	7.53	7.53	7.53	7.53
Reserves Total	25.89	22.10	16.86	12.73	10.73	9.52
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	33.42	29.63	24.39	20.26	18.26	17.05
Secured Loans	10.61	5.10	7.23	19.57	16.69	13.56
Unsecured Loans	25.24	17.97	23.23	8.03	5.37	5.61
Total Debt	35.85	23.07	30.46	27.60	22.06	19.17
Total Liabilities	69.27	52.70	54.85	47.86	40.32	36.22
APPLICATION OF FUNDS :
Gross Block	46.28	49.57	44.05	34.21	34.20	32.70
Less : Accumulated Depreciation	21.37	23.32	21.62	20.40	19.23	18.15
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	24.91	26.25	22.43	13.81	14.97	14.55
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	9.08	0.49	0.76	8.93	2.05	0.97
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	19.86	10.03	14.65	17.75	16.47	13.47
Sundry Debtors	57.93	55.58	45.12	36.02	33.96	26.78
Cash and Bank	3.08	2.28	1.64	1.43	1.53	1.62
Loans and Advances	6.13	6.45	6.20	5.63	4.55	5.42
Total Current Assets	87.01	74.33	67.61	60.83	56.50	47.28
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	48.79	45.25	33.35	34.43	31.81	24.57
Provisions	1.02	1.23	1.19	0.39	0.36	0.27
Total Current Liabilities	49.81	46.47	34.54	34.82	32.17	24.84
Net Current Assets	37.20	27.86	33.08	26.01	24.32	22.45
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.74	0.04
Deferred Tax Liability	1.65	1.51	0.97	0.57	1.42	1.46
Net Deferred Tax	-1.65	-1.51	-0.97	-0.57	-0.68	-1.42
Total Assets	69.54	53.09	55.30	48.18	40.66	36.55
Contingent Liabilities	0.50	0.39	0.39	0.37	0.37	0.43

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	2.28	1.64	1.43	1.53	1.62
Net Cash from Operating Activities	13.22	11.23	1.33	6.24	3.71
Net Cash Used In Investing Activities	-8.64	-4.97	-1.25	-6.68	-2.34
Net Cash Used In Financing Activities	-3.77	-5.62	0.13	0.34	-1.46
Net Inc./Dec In Cash And Cash Equivalents	0.81	0.64	0.21	-0.10	-0.09
Cash And Cash Equivalents At End Of The Year	3.08	2.28	1.64	1.43	1.53

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

53.16%

FII Shareholding

0.00%

DII Shareholding

0.50%

Public Shareholding

46.34%

**Promoter pledged shareholding 53.16%

About Godavari Drugs Ltd

Godavari Drugs Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 75.3 crores. It has reported a sales of Rs. 43.11 crores and a net profit of Rs. 1.22 crores for the quarter ended December 2018. The company management includes Ghanshyam Jaju, Mukund Kakani,S A Hussain,Mohit Jaju,Ramesh Babu Telugu,Vimala B Madon,Ghanshyam Jaju,Mahindra Uday Bhalerao,Venkatesh Achanta (Godavari Drugs Ltd) among others.

Chairman

Ghanshyam Jaju

Registered office

Mayfair 1-8-303-34,Sardar Patel Road,Secunderabad,Andhra Pradesh,500003

FAX :91-40-27849859

Background

Incorporation Year1987

Face Value₹10

Market Lot1

How to buy Godavari Drugs shares on nse?

To buy Godavari Drugs shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Godavari Drugs share price today?

The Godavari Drugs shares price on nse is Rs.100 today.

What is the market cap of Godavari Drugs shares on BSE ?

The company has a market capitalization of Rs.75.30Cr

What is the PE & PB ratio of Godavari Drugs shares ?

PE is 18.55 and PB is 2.15

What is the 52 Week High and Low of Godavari Drugs shares?

Godavari Drugs stock price high: Rs.114 Godavari Drugs stock price low: Rs.76.21